Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), comprising the first 29 amino acids of the naturally occurring 44-amino-acid GHRH sequence. As the shortest fully functional GHRH fragment, it stimulates the pituitary gland to produce and release growth hormone in a physiologically regulated manner. Research focuses on age-related decline in growth hormone secretion.

Tirzepatide is a 39-amino-acid synthetic peptide that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This first-in-class "twincretin" features a C20 fatty di-acid moiety for extended duration of action. Research demonstrates significant effects on metabolic parameters, glycemic control, and body composition.

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino-acid peptide encoded within the mitochondrial genome. As a mitochondrial-derived peptide (MDP), it represents a novel class of signaling molecules. Research has investigated its role in metabolic homeostasis, exercise mimetic effects, insulin sensitivity, and cellular stress responses. MOTS-c is considered a key regulator of the nuclear genome by mitochondria.

Semaglutide is a 31-amino-acid glucagon-like peptide-1 (GLP-1) receptor agonist with 94% homology to native GLP-1. Modified with a C18 fatty di-acid chain attached via a spacer to the lysine at position 26, this modification enables extended half-life through albumin binding. Research has extensively studied its effects on glycemic control, appetite regulation, and body weight management.

TB-500 (Thymosin Beta-4) is a naturally occurring 43-amino-acid peptide present in virtually all human and animal cells. As a major actin-sequestering protein, it plays a crucial role in cell migration, proliferation, and differentiation. Research has focused on its potential effects on tissue repair, wound healing, and recovery from injury. TB-500 is studied for its ability to promote angiogenesis and reduce inflammation.

AOD-9604 (Anti-Obesity Drug 9604) is a modified fragment of human growth hormone comprising amino acids 177-191. This 15-amino-acid peptide was originally developed to study fat metabolism without affecting IGF-1 levels or insulin resistance. Research has investigated its potential lipolytic effects and its role in cartilage and bone repair.

Retatrutide is a novel 39-amino-acid triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This triple agonist approach represents a new paradigm in metabolic research. Early studies have shown remarkable effects on body weight reduction and metabolic parameters, with Phase 2 trials demonstrating unprecedented efficacy in weight management research.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. This 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) has garnered significant research interest for its potential role in tissue repair, wound healing, and regeneration. Studies have investigated its effects on tendons, ligaments, muscle, and the gastrointestinal tract.

Selank is a synthetic heptapeptide analog of the naturally occurring immunomodulatory peptide tuftsin, with an additional Pro-Gly-Pro sequence for enhanced stability. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, research has investigated its anxiolytic, nootropic, and immunomodulatory properties. Studies suggest effects on BDNF expression and monoamine neurotransmitter balance.

Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10) with a C-terminal Pro-Gly-Pro modification for enhanced stability. Originally developed as a neuroprotective agent, research has investigated its cognitive-enhancing, neuroprotective, and neurotrophic properties. Studies suggest effects on BDNF, NGF, and various neurotransmitter systems.

This research blend combines two of the most studied tissue repair peptides: BPC-157 (5mg) and TB-500 (5mg). BPC-157 is a 15-amino-acid gastric pentadecapeptide with research focus on tissue repair and gut healing. TB-500 is a 43-amino-acid fragment of Thymosin Beta-4 studied for actin regulation and wound healing. Together, they represent complementary mechanisms for tissue repair research.

The GLOW Blend combines three synthetic peptides studied for their roles in cellular regeneration and repair processes: GHK-Cu, BPC-157, and TB-500. Together, these peptides are investigated for their influence on angiogenesis, extracellular matrix remodeling, and systemic repair pathways.

The KLOW Blend combines GHK-Cu, BPC-157, TB-500, and KPV into a single formulation studied for its potential influence on cellular repair and systemic regulation. The inclusion of KPV supports immune regulation and anti-inflammatory pathways.

This growth hormone secretagogue blend combines CJC-1295 without DAC (5mg) and Ipamorelin (5mg). CJC-1295 without DAC (also known as Mod GRF 1-29) is a 29-amino-acid GHRH analog that stimulates growth hormone release. Ipamorelin is a selective pentapeptide ghrelin receptor agonist. Together, they work synergistically through GHRH and GHSR pathways for comprehensive growth hormone research.

Nicotinamide Adenine Dinucleotide (NAD+) is a critical coenzyme found in all living cells. As an essential cofactor for over 500 enzymatic reactions, NAD+ plays crucial roles in energy metabolism, DNA repair, gene expression, and cellular signaling. Research has extensively investigated age-related NAD+ decline and the potential benefits of NAD+ supplementation on cellular function, metabolism, and longevity pathways including sirtuins.

Ipamorelin is a selective pentapeptide growth hormone secretagogue and ghrelin receptor (GHSR) agonist. Unlike other GH secretagogues, ipamorelin demonstrates high selectivity, stimulating growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels. This selective profile makes it a preferred research tool for studying growth hormone physiology.

Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the full 44-amino-acid sequence with a trans-3-hexenoic acid modification at the N-terminus. This modification enhances stability and bioavailability. Research has investigated its effects on growth hormone secretion, body composition, and visceral adipose tissue reduction.

GHK-Cu (Copper peptide GHK-Cu, Glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. Levels decline significantly with age, from ~200 ng/mL at age 20 to ~80 ng/mL by age 60. Research has investigated its effects on collagen synthesis, wound healing, skin remodeling, antioxidant enzyme expression, and anti-inflammatory activity.

Sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative. Used for reconstitution of lyophilized peptides. Each vial is pharmaceutical grade and suitable for research applications.